In our study, we found a reduction of the membrane form of OX40 on CD3+, CD4+, and CD8+ T cells and a reduction of OX40L on CD14+ monocytes in T1D patients correlated with clinical parameters. This evidence concerns the gene CD14 and type 1 diabetes mellitus.